Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Freenome Raises $270M In Series C, Accelerates Trial For Colorectal Cancer Test

Aug 26 2020

• By Marion Webb

Freenome Lab Employee

Related Content

Freenome Scores $160M In New Funding. So What's Next?

Jul 31 2019

Guardant Health Expects FDA Approval Of Liquid Biopsy Test Will Strengthen Coverage, Adoption

Aug 11 2020

Partnerships Are Key To Foundation Medicine's Success

Jan 03 2020

Grail Raises $390M In Series D Financing To Advance Blood Cancer Test

May 08 2020

Related Companies

Guardant Health, Inc.

Additional Topics

Financing Clinical Trials Coronavirus COVID-19 Artificial Intelligence Commercial In Vitro Diagnostics Cancer Diagnostics Medical Device

More from In Vitro Diagnostics

More from Diagnostics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window